A detailed history of Tbh Global Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tbh Global Asset Management, LLC holds 7,075 shares of ABBV stock, worth $1.26 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
7,075
Previous 7,255 2.48%
Holding current value
$1.26 Million
Previous $1.24 Million 12.3%
% of portfolio
0.31%
Previous 0.28%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $29,491 - $35,879
-180 Reduced 2.48%
7,075 $1.4 Million
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $60,522 - $70,677
-391 Reduced 5.11%
7,255 $1.24 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $72,238 - $82,309
452 Added 6.28%
7,646 $1.39 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $46,921 - $52,844
-341 Reduced 4.53%
7,194 $1.11 Million
Q3 2023

Oct 31, 2023

BUY
$133.59 - $154.65 $1,202 - $1,391
9 Added 0.12%
7,535 $1.12 Million
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $1,855 - $2,308
-14 Reduced 0.19%
7,526 $1.01 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $37,887 - $43,633
262 Added 3.6%
7,540 $1.2 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $12,171 - $14,596
88 Added 1.22%
7,278 $1.18 Million
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $1,342 - $1,539
10 Added 0.14%
7,190 $965,000
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $23,670 - $30,093
172 Added 2.45%
7,180 $1.1 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $1,055 - $1,310
8 Added 0.11%
7,008 $1.14 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $6,230 - $7,883
58 Added 0.84%
7,000 $948,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $13,087 - $14,855
123 Added 1.8%
6,942 $749,000
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $631 - $703
6 Added 0.09%
6,819 $768,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $14,424 - $15,879
141 Added 2.11%
6,813 $737,000
Q4 2020

Feb 04, 2021

SELL
$80.49 - $108.67 $44,349 - $59,877
-551 Reduced 7.63%
6,672 $715,000
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $77,748 - $91,251
905 Added 14.32%
7,223 $633,000
Q2 2020

Jul 23, 2020

BUY
$73.37 - $98.18 $293 - $392
4 Added 0.06%
6,318 $620,000
Q1 2020

Apr 23, 2020

BUY
$64.5 - $97.79 $193 - $293
3 Added 0.05%
6,314 $481,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $455,212 - $569,567
6,311 New
6,311 $559,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tbh Global Asset Management, LLC Portfolio

Follow Tbh Global Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tbh Global Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tbh Global Asset Management, LLC with notifications on news.